体内因子VIII回收率和半衰期的计算。 - Suppr

Suppr

超能文献

Calculations of factor VIII in vivo recovery and half-life.

作者信息

Kjellman H

出版信息

Scand J Haematol Suppl. 1984;40:165-74. doi: 10.1111/j.1600-0609.1984.tb02560.x.

DOI:10.1111/j.1600-0609.1984.tb02560.x

PMID:6433448

Abstract

摘要

相似文献

Calculations of factor VIII in vivo recovery and half-life.体内因子VIII回收率和半衰期的计算。

Scand J Haematol Suppl. 1984;40:165-74. doi: 10.1111/j.1600-0609.1984.tb02560.x.

Principles of in vivo recovery and survival studies.体内恢复与存活研究的原则。

Scand J Haematol Suppl. 1984;40:161-3. doi: 10.1111/j.1600-0609.1984.tb02559.x.

The importance of corticoids added to continued treatment with Factor VIII concentrates in the suppression of inhibitors in haemophilia A.

Thromb Haemost. 1984 Apr 30;51(2):217-21.

Characteristics of various factor VIII concentrates used in treatment of haemophilia A.用于治疗甲型血友病的各种凝血因子VIII浓缩剂的特性。

Br J Haematol. 1977 Dec;37(4):543-57. doi: 10.1111/j.1365-2141.1977.tb01028.x.

Comparison of the in vivo survival of human factor VIII with and without von Willebrand factor in the hemophilic dog.血友病犬体内人凝血因子VIII在有和没有血管性血友病因子情况下的存活情况比较。

Thromb Res. 1986 Feb 1;41(3):425-9. doi: 10.1016/0049-3848(86)90253-7.

Is a change of factor VIII product a risk factor for the development of a factor VIII inhibitor?

Thromb Haemost. 1999 May;81(5):852.

Fractionation of factor VIII and IX--an overview.凝血因子 VIII 和 IX 的分级分离——概述。

Scand J Haematol Suppl. 1984;40:513-24. doi: 10.1111/j.1600-0609.1984.tb02611.x.

The 'in vivo' survival characteristics of factor VIII procoagulant antigen (VIII:C Ag) in haemophilia A subjects.

Thromb Res. 1982;25(1-2):33-9. doi: 10.1016/0049-3848(82)90212-2.

In vivo characteristics of thaw siphon cryoprecipitate compared to other factor VIII preparations.与其他凝血因子 VIII 制剂相比，解冻虹吸冷沉淀的体内特性。

Thromb Haemost. 1980 Feb 29;43(1):25-7.

Heparin and factor VIII.肝素与凝血因子 VIII。

Scand J Haematol Suppl. 1984;40:111-22. doi: 10.1111/j.1600-0609.1984.tb02552.x.

引用本文的文献

The History of Clotting Factor Concentrates Pharmacokinetics.凝血因子浓缩物药代动力学的历史

J Clin Med. 2017 Mar 20;6(3):35. doi: 10.3390/jcm6030035.

Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.凝血因子的药代动力学：对血友病患者的临床意义

Clin Pharmacokinet. 2001;40(11):815-32. doi: 10.2165/00003088-200140110-00003.

Clinical pharmacokinetics of factor VIII in patients with classic haemophilia.

Clin Pharmacokinet. 1987 Dec;13(6):365-80. doi: 10.2165/00003088-198713060-00002.

Factor VIII concentrate for hemophilia: comparison of two heat-treated products.用于血友病的凝血因子 VIII 浓缩剂：两种热处理产品的比较。

CMAJ. 1987 Jan 15;136(2):150-2.

Pharmacokinetics of factor VIII in humans. Obtaining clinically relevant data from comparative studies.人凝血因子 VIII 的药代动力学。从比较研究中获取临床相关数据。

Clin Pharmacokinet. 1992 May;22(5):385-95. doi: 10.2165/00003088-199222050-00005.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验